Marina V.
- Country
- Italy
- Department
- Laboratorio Nefrologia
Research Overview
- Rituximab-Based Memory B Cell Level-Guided Therapy in Pediatric Complicated Steroid-Sensitive Nephrotic Syndrome: A Randomized Controlled Trial
- Real‑World Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex MPGN: Multi‑Country Observational Study
- A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis (IC-MPGN)
Data & Insights
Has run more than one trial at 91 of 160 partner sites.
Specializations
Glomerular Disorders
This investigator specializes in treating various forms of glomerulonephritis, with particular focus on C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis.
- Complement-mediated kidney diseases
- Proteinuric glomerular conditions
- Immune complex disorders
Advanced therapeutic approaches are explored for both native and transplanted kidney manifestations.
Pediatric Nephrology
Focuses on treating kidney disorders in children, particularly steroid-sensitive nephrotic syndrome and chronic kidney disease with proteinuria.
- Memory B cell-based treatments
- Proteinuria management in children
- Long-term renal care strategies
Specializes in tailored therapeutic approaches for pediatric kidney conditions.
Autoimmune Kidney Conditions
Expertise in treating lupus nephritis and related autoimmune kidney disorders, with special attention to pediatric and adolescent populations.
- Class III/IV lupus nephritis
- Focal segmental glomerulosclerosis
- IgA nephropathy
Implements innovative treatment protocols for complex autoimmune kidney conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.